Home NDC 63833-829-02 HAEGARDA
Product NDC 63833-829
Requested package NDC 63833-829-02
11-digit product format 638330829
Labeler code 63833
Product ID 63833-829_c53fd34d-f366-4ee5-bbea-88201bf6b7c8
Type PLASMA DERIVATIVE
Nonproprietary name HUMAN C1-ESTERASE INHIBITOR
Dosage form KIT
Labeler CSL Behring GmbH
Application BLA125606
Marketing category BLA
Marketing start 2017-06-22
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base HAEGARDA
Brand name suffix C1 Esterase Inhibitor Subcutaneous (Human)
Listing expiration 2026-12-31
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1926818 Internal RxNorm lookup 1926823 Internal RxNorm lookup 1926825 Internal RxNorm lookup 1926827 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63833-829-02 HAEGARDAC1 Esterase Inhibitor Subcutaneous (Human) 1 in 1 CARTON KIT 1 8 63833-839-01 HAEGARDAC1 Esterase Inhibitor Subcutaneous (Human) 5.6 mL in 1 VIAL, SINGLE-USE INJECTION, POWDER, FOR SOLUTION 6 mL 3000 [iU] in 6mL 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63833-829 HAEGARDA C1 ESTERASE INHIBITOR SUBCUTANEOUS (HUMAN) (HUMAN C1-ESTERASE INHIBITOR) KIT [CSL BEHRING GMBH] 8 Current NDC, Legacy NDC, 2 package rows 20220831_e270ad38-adc4-4ed5-88e3-943b93d20a57.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125606 Haegarda C1 Esterase Inhibitor Subcutaneous (Human) 351(a) Rx 2026-10-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 63833-829-02 63833082902 1 KIT in 1 CARTON (63833-829-02) * 5.6 mL in 1 VIAL, SINGLE-USE (63833-839-01) * 5.6 mL in 1 VIAL, SINGLE-USE (63833-765-19) 1 kit 2017-06-22 0000-00-00 No No Current